SCHEMBL1324636

SCHEMBL1324636

O=C(/C=C/c1ccc(F)cc1)NS(=O)(=O)/C=C/c1ccc(F)cc1.O=S(=O)(/C=C\c1ccc(F)cc1)NS(=O)(=O)/C=C/c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
KMT2A Q03164 6/20 0.49
PKM P14618 1/20 0.49
HSD11B1 P28845 1/20 0.49
MEN1 O00255 3/20 0.48
MMP1 P03956 2/20 0.48
MMP2 P08253 2/20 0.48
MMP9 P14780 2/20 0.48
LMNA P02545 2/20 0.47
TP53 P04637 1/20 0.47
EGFR P00533 1/20 0.46
TNFRSF1A P19438 1/20 0.45
MAOB P27338 1/20 0.45
DHODH Q02127 1/20 0.44
HPGD P15428 1/20 0.44
TRPA1 O75762 1/20 0.44
POLB P06746 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1323541 0.95 HSD11B1 (0.53) CA12CA1CA2CA9KMT2A
SCHEMBL1323498 0.95 HSD11B1 (0.53) CA12CA1CA2CA9KMT2A
SCHEMBL1323502 0.95 HSD11B1 (0.53) CA12CA1CA2CA9KMT2A
SCHEMBL1324218 0.95 HSD11B1 (0.53) CA12CA1CA2CA9KMT2A
SCHEMBL1324753 0.85 HDAC2 (0.53) CA12CA1CA2CA9MMP1
SCHEMBL1324278 0.85 HDAC1 (0.39) KMT2AMMP1MMP2MMP9LMNA
SCHEMBL1324751 0.85 HDAC2 (0.53) CA12CA1CA2CA9MMP1
SCHEMBL1324397 0.85 CYP1A2 (0.46) KMT2AMEN1LMNATRPA1POLB
SCHEMBL1324399 0.85 CYP1A2 (0.46) KMT2AMEN1LMNATRPA1POLB
SCHEMBL1324281 0.85 HDAC1 (0.39) KMT2AMMP1MMP2MMP9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058313-B2 4-((1E)-2-(((E)-2-fluoro-4-cyanostyrylsulfonyl)methylsulfonyl)vinyl)-3-fluoro-benzonitrile; mitogen activated protein kinase inhibitor; cell growth factor receptor antagonist; angiogenesis inhibitor, antiproliferative and anticarcinogenic agent; neurodegenerative diseases Temple University—Of the Commonwealth System of Higher Education (US) 2011-11-15 US claimed